DXCM Stock Recent News

DXCM LATEST HEADLINES

DXCM Stock News Image - seekingalpha.com

DexCom focuses on continuous glucose monitoring systems, with a strong market position and global reach. Q1 results showed 13% revenue growth, beating expectations, though earnings were slightly below consensus. Analysts remain bullish, with most issuing Buy ratings and price targets ranging from $87 to $110 per share.

seekingalpha.com 2025 Jul 21
DXCM Stock News Image - zacks.com

Here is how DexCom (DXCM) and Amarin (AMRN) have performed compared to their sector so far this year.

zacks.com 2025 Jul 21
DXCM Stock News Image - fool.com

Medical device specialist DexCom (DXCM -0.33%) has encountered significant headwinds in the past year. The company's financial results haven't been quite up to the market's standards, and broader market volatility caused by President Donald Trump's trade policies isn't helping either.

fool.com 2025 Jul 20
DXCM Stock News Image - businesswire.com

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fourth season of Dexcom U, the company's one-of-a-kind NIL (Name, Image and Likeness) program exclusively for college athletes with diabetes. This year's Dexcom U roster welcomes 13 new athletes from colleges and universities across the country — including the University of Oregon, San Diego State University, and Northwestern University — representing 12 sports suc.

businesswire.com 2025 Jul 17
DXCM Stock News Image - zacks.com

DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

zacks.com 2025 Jul 14
DXCM Stock News Image - globenewswire.com

SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (NASDAQ: DXCM) for potential breaches of fiduciary duties and violations of the federal securities laws.

globenewswire.com 2025 Jul 09
DXCM Stock News Image - fool.com

One of Warren Buffett's famous pieces of investing advice is to be greedy when others are fearful. One way to apply this wisdom is to look for companies that have lagged the market recently but still appear to be excellent long-term investment opportunities.

fool.com 2025 Jul 06
DXCM Stock News Image - zacks.com

Here is how DexCom (DXCM) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.

zacks.com 2025 Jul 03
DXCM Stock News Image - zacks.com

DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.

zacks.com 2025 Jul 02
DXCM Stock News Image - investors.com

Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for wearable diabetes tech.

investors.com 2025 Jul 01
10 of 50